Dr. Pasquali is a Clinical Biochemical Geneticist at the University of Utah and ARUP Laboratories.' She is Medical Director of Biochemical Genetics at ARUP Laboratories. Her focus is development of new methods for the screening and the diagnosis of inherited metabolic disorders, with emphasis on disorders of carnitine and creatine metabolism and transport and lysosomal storage disorders. She is also the Program Director of the ACGME accredited Fellowship program in Clinical Biochemical Genetics at the University of Utah.

Dr. Jay'is a Voluntary Clinical Professor at Wayne State University School of Medicine in the Center for Molecular Medicine and Genetics, and Director of Henry Ford St. John's Cancer Genetics program. Dr. Jay is Board Certified in Clinical Genetics, Medical Biochemical Genetics, and Clinical Biochemical Genetics. Dr. Jay completed the City of Hope Intensive Course in Cancer Risk Assessment in 2017, and remains active in the City of Hope community of practice.' Dr. Jay attended the University of Chicago Pritzker School of Medicine, then completed a residency at Wayne State in Genetics, and a fellowship at the Mayo Clinic in Biochemical Genetics.' Dr. Jay is involved in multidisciplinary clinical work and training of the rotating medical students, pediatric residents, obstetrics/gynecology residents, and hematology/oncology fellows in genetic cancer risk assessment.' In addition to her cancer genetics duties, she is active in doing consultations for the Henry Ford St. John Pediatrics department.' Her research focuses on genetic counseling and health equity with telehealth, and providing resources to decrease financial toxicity related to genetic testing for cancer patients. She is a member of the American Medical Association, the American College of Medical Genetics, and Society of Inherited Metabolic Disease

Dr. Anastasio is a clinical and laboratory geneticist at the Sherbrooke University hospital in Quebec, Canada. Following her Medical Genetics residency at McGill University, she pursued a fellowship in Laboratory Molecular Genetics in both Boston (The Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine) and Montreal (McGill University). She began practicing in 2021 and splits her time between clinical and laboratory work. Since October 2025, she is the chief of the Medical Genetics Service, Clinical and Laboratory sectors. She is also actively involved in teaching of medical students, residents and undergraduate students.

Suma Shankar MD, PhD, FRCS, MRCOphth is a Professor in the Departments of Pediatrics and Ophthalmology and is Chief of Genomic Medicine at University of California Davis. She serves as the Director of Precision Genomic Program and Ocular Genomics clinic at UC Davis and holds the Albert Rowe Endowed Chair of Genetics II. She sees patients with a wide range of genetic disorders with special interest and expertise in Ophthalmic Genetic disorders, RASopathies and Nonverbal ASD and NDDs. The Genomic Medicine team provide comprehensive clinical genetics services including facilitation of whole genome sequencing, genetic counseling, and management of genetic disorders. She directs the Precision Genomics program for clinical translational research collaborating with Mouse Biology Program, Stem cell research program, Clinical and bioinformatics programs at UC Davis.

Dr. Margaret Adam is a pediatric geneticist/dysmorphologist at the University of Washington/Seattle Children's Hospital and is Editor-in-Chief of GeneReviews.' She specializes in the diagnosis and management of dysmorphic syndromes.' She is actively involved in clinical research on Mowat-Wilson syndrome, Kabuki syndrome, and Differences of Sex Development.' In addition, her clinical interests include teratology, for which she serves as a dysmorphologist on several national/international clinical research studies on Fetal Alcohol Syndrome and the newer generation biologics used to treat maternal autoimmune diseases.